Personal tools

CL:0000765: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{CL
{{CL
|id=CL:0000765
|alt_id=
|name=erythroblast
|namespace=efo
|def="A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers." [GOC:add, ISBN:0721601464, PMID:18174176]
|xref=BTO:0001571;;FMA:83504
|is_a=CL:0000764
|synonym="normoblast" EXACT []
|comment=
|comment=
|alt_id=
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def="A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers." [GOC:add, ISBN:0721601464, PMID:18174176]
|subset=
|adjacent_to=
|derives_from=
|derives_from=
|develops_from=CL:0000547
|develops_from=CL:0000547
|disjoint_from=
|has_quality=
|has_quality=
|id=CL:0000765
|is_a=CL:0000764 ;;CL:0002242
|is_obsolete=
|located_in=
|located_in=
|name=erythroblast
|namespace=FANTOM
|obo_creation_date=
|part_of=
|part_of=
|property_value=IAO:0000412 http://purl.obolibrary.org/obo/cl.owl;;IAO:0000412 http://purl.obolibrary.org/obo/efo.obo.owl
|is_obsolete=
|preceded_by=
|preceded_by=
|property_value=IAO:0000412 http://purl.obolibrary.org/obo/cl.owl;;IAO:0000412 http://purl.obolibrary.org/obo/efo.owl
|subset=
|synonym="normoblast" EXACT []
|union_of=
|xref=BTO:0001571;;FMA:83504
}}
}}

Latest revision as of 16:36, 12 September 2014

Name:erythroblast
Namespace:FANTOM
Definition:"A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers." [GOC:add, ISBN:0721601464, PMID:18174176]
Xrefs:
links:

BTO:0001571

FMA:83504
Synonyms: "normoblast" EXACT []


Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

Parents

is_a:CL:0000764(erythroid lineage cell),CL:0002242(nucleate cell)
develops_from:CL:0000547(proerythroblast)



Children


is a:CL:0000549 (basophilic erythroblast),CL:0000550 (polychromatophilic erythroblast),CL:0000552 (orthochromatic erythroblast)
derives from:FF:0000401 (erythroblastic leukemia cell line sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)


FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

Human (Homo sapiens)

  • 13063-139I3 (J2E erythroblastic leukemia response to erythropoietin)
  • 13064-139I4 (J2E erythroblastic leukemia response to erythropoietin)
  • 13065-139I5 (J2E erythroblastic leukemia response to erythropoietin)
  • 13066-139I6 (J2E erythroblastic leukemia response to erythropoietin)
  • 13067-139I7 (J2E erythroblastic leukemia response to erythropoietin)
  • 13068-139I8 (J2E erythroblastic leukemia response to erythropoietin)
  • 13069-139I9 (J2E erythroblastic leukemia response to erythropoietin)
  • 13070-140A1 (J2E erythroblastic leukemia response to erythropoietin)
  • 13071-140A2 (J2E erythroblastic leukemia response to erythropoietin)
  • 13072-140A3 (J2E erythroblastic leukemia response to erythropoietin)

... further results Mouse (Mus musculus)

  • 13063-139I3 (J2E erythroblastic leukemia response to erythropoietin)
  • 13064-139I4 (J2E erythroblastic leukemia response to erythropoietin)
  • 13065-139I5 (J2E erythroblastic leukemia response to erythropoietin)
  • 13066-139I6 (J2E erythroblastic leukemia response to erythropoietin)
  • 13067-139I7 (J2E erythroblastic leukemia response to erythropoietin)
  • 13068-139I8 (J2E erythroblastic leukemia response to erythropoietin)
  • 13069-139I9 (J2E erythroblastic leukemia response to erythropoietin)
  • 13070-140A1 (J2E erythroblastic leukemia response to erythropoietin)
  • 13071-140A2 (J2E erythroblastic leukemia response to erythropoietin)
  • 13072-140A3 (J2E erythroblastic leukemia response to erythropoietin)

... further results


Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000765 (erythroblast), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

P-valueFFCPShort description
3.29e-195FFCP PHASE2:Hg19::chr1:158580993..158580998,-#_eae95161532de1661d492f51cb15464fp@chr1:158580993..158580998, -
3.29e-195FFCP PHASE1:Hg19::chr1:158580993..158580998,-#_eae95161532de1661d492f51cb15464fp@chr1:158580993..158580998, -
3.29e-195FFCP PHASE1:Hg19::chr11:115492263..115492265,+#_eae95161532de1661d492f51cb15464fp@chr11:115492263..115492265, +
3.29e-195FFCP PHASE2:Hg19::chr11:66676050..66676060,+#_eae95161532de1661d492f51cb15464fp@chr11:66676050..66676060, +
3.29e-195FFCP PHASE2:Hg19::chr10:86596455..86596456,+#_eae95161532de1661d492f51cb15464fp@chr10:86596455..86596456, +
3.29e-195FFCP PHASE1:Hg19::chr18:11740276..11740278,+#_eae95161532de1661d492f51cb15464fp@chr18:11740276..11740278, +
3.29e-195FFCP PHASE1:Hg19::chr9:138852021..138852030,+#_eae95161532de1661d492f51cb15464fp@chr9:138852021..138852030, +
3.29e-195FFCP PHASE1:Hg19::chr11:57416011..57416016,+#_eae95161532de1661d492f51cb15464fp9@CLP1
3.29e-195FFCP PHASE1:Hg19::chr13:106256314..106256318,+#_eae95161532de1661d492f51cb15464fp@chr13:106256314..106256318, +
3.29e-195FFCP PHASE1:Hg19::chr12:131245491..131245492,+#_eae95161532de1661d492f51cb15464fp@chr12:131245491..131245492, +
3.29e-195FFCP PHASE1:Hg19::chr6:10585672..10585677,+#_eae95161532de1661d492f51cb15464fp42@GCNT2
3.29e-195FFCP PHASE2:Hg19::chr11:5247692..5247701,-#_eae95161532de1661d492f51cb15464fp@chr11:5247692..5247701, -
3.29e-195FFCP PHASE2:Hg19::chr4:160049078..160049079,+#_eae95161532de1661d492f51cb15464fp@chr4:160049078..160049079, +
3.29e-195FFCP PHASE1:Hg19::chr9:123853258..123853276,-#_eae95161532de1661d492f51cb15464fp@chr9:123853258..123853276, -
3.29e-195FFCP PHASE2:Hg19::chr6:10585684..10585689,+#_eae95161532de1661d492f51cb15464fp37@GCNT2
3.29e-195FFCP PHASE2:Hg19::chr8:101412217..101412218,+#_eae95161532de1661d492f51cb15464fp@chr8:101412217..101412218, +
3.29e-195FFCP PHASE2:Hg19::chr4:26378984..26378987,+#_eae95161532de1661d492f51cb15464fp@chr4:26378984..26378987, +
3.29e-195FFCP PHASE1:Hg19::chr16:15616042..15616045,+#_eae95161532de1661d492f51cb15464fp@chr16:15616042..15616045, +
3.29e-195FFCP PHASE2:Hg19::chr3:49726589..49726592,+#_eae95161532de1661d492f51cb15464fp7@RNF123
3.29e-195FFCP PHASE1:Hg19::chr4:26378984..26378987,+#_eae95161532de1661d492f51cb15464fp@chr4:26378984..26378987, +
3.29e-195FFCP PHASE1:Hg19::chr3:49726589..49726592,+#_eae95161532de1661d492f51cb15464fp7@RNF123
3.29e-195FFCP PHASE2:Hg19::chr11:5255612..5255613,-#_eae95161532de1661d492f51cb15464fp10@HBD
3.29e-195FFCP PHASE1:Hg19::chr17:27188395..27188398,-#_eae95161532de1661d492f51cb15464fp1@MIR451A
3.29e-195FFCP PHASE2:Hg19::chr9:45465498..45465501,+#_eae95161532de1661d492f51cb15464fp@chr9:45465498..45465501, +
3.29e-195FFCP PHASE2:Hg19::chr13:78682773..78682778,+#_eae95161532de1661d492f51cb15464fp@chr13:78682773..78682778, +
3.29e-195FFCP PHASE2:Hg19::chr11:57415965..57415973,+#_eae95161532de1661d492f51cb15464fp5@CLP1
3.29e-195FFCP PHASE2:Hg19::chr2:112191654..112191660,-#_eae95161532de1661d492f51cb15464fp@chr2:112191654..112191660, -
3.29e-195FFCP PHASE2:Hg19::chr11:29581179..29581180,+#_eae95161532de1661d492f51cb15464fp@chr11:29581179..29581180, +
3.29e-195FFCP PHASE1:Hg19::chr2:112191654..112191660,-#_eae95161532de1661d492f51cb15464fp@chr2:112191654..112191660, -
3.29e-195FFCP PHASE1:Hg19::chr12:75560876..75560881,+#_eae95161532de1661d492f51cb15464fp@chr12:75560876..75560881, +
3.29e-195FFCP PHASE2:Hg19::chr14:55799575..55799582,+#_eae95161532de1661d492f51cb15464fp@chr14:55799575..55799582, +
3.29e-195FFCP PHASE2:Hg19::chr1:25598961..25598966,+#_eae95161532de1661d492f51cb15464fp5@RHD
3.29e-195FFCP PHASE2:Hg19::chr16:227522..227524,+#_eae95161532de1661d492f51cb15464fp@chr16:227522..227524, +
3.29e-195FFCP PHASE1:Hg19::chr1:25598961..25598966,+#_eae95161532de1661d492f51cb15464fp5@RHD
3.29e-195FFCP PHASE2:Hg19::chr1:207823590..207823599,+#_eae95161532de1661d492f51cb15464fp@chr1:207823590..207823599, +
3.29e-195FFCP PHASE1:Hg19::chr4:160049078..160049079,+#_eae95161532de1661d492f51cb15464fp@chr4:160049078..160049079, +
3.29e-195FFCP PHASE1:Hg19::chr14:96742091..96742094,-#_eae95161532de1661d492f51cb15464fp@chr14:96742091..96742094, -
3.29e-195FFCP PHASE1:Hg19::chr10:86596455..86596456,+#_eae95161532de1661d492f51cb15464fp@chr10:86596455..86596456, +
3.29e-195FFCP PHASE2:Hg19::chr11:5248435..5248444,+#_eae95161532de1661d492f51cb15464fp@chr11:5248435..5248444, +
3.29e-195FFCP PHASE1:Hg19::chr6:10585684..10585689,+#_eae95161532de1661d492f51cb15464fp37@GCNT2
3.29e-195FFCP PHASE1:Hg19::chr15:71406717..71406718,+#_eae95161532de1661d492f51cb15464fp@chr15:71406717..71406718, +
3.29e-195FFCP PHASE1:Hg19::chr8:101412217..101412218,+#_eae95161532de1661d492f51cb15464fp@chr8:101412217..101412218, +
3.29e-195FFCP PHASE1:Hg19::chr17:42366115..42366125,+#_eae95161532de1661d492f51cb15464fp@chr17:42366115..42366125, +
3.29e-195FFCP PHASE2:Hg19::chr11:5247730..5247736,-#_eae95161532de1661d492f51cb15464fp@chr11:5247730..5247736, -
3.29e-195FFCP PHASE2:Hg19::chr6:50700492..50700495,+#_eae95161532de1661d492f51cb15464fp@chr6:50700492..50700495, +
3.29e-195FFCP PHASE1:Hg19::chr6:50700492..50700495,+#_eae95161532de1661d492f51cb15464fp@chr6:50700492..50700495, +
3.29e-195FFCP PHASE1:Hg19::chr9:45465498..45465501,+#_eae95161532de1661d492f51cb15464fp@chr9:45465498..45465501, +
3.29e-195FFCP PHASE2:Hg19::chrX:107332036..107332041,+#_eae95161532de1661d492f51cb15464fp@chrX:107332036..107332041, +
3.29e-195FFCP PHASE1:Hg19::chrX:107332036..107332041,+#_eae95161532de1661d492f51cb15464fp@chrX:107332036..107332041, +
3.29e-195FFCP PHASE1:Hg19::chr11:5247692..5247701,-#_eae95161532de1661d492f51cb15464fp@chr11:5247692..5247701, -
3.29e-195FFCP PHASE2:Hg19::chr3:49726593..49726603,+#_eae95161532de1661d492f51cb15464fp4@RNF123
3.29e-195FFCP PHASE1:Hg19::chr3:49726593..49726603,+#_eae95161532de1661d492f51cb15464fp4@RNF123
3.29e-195FFCP PHASE2:Hg19::chr16:67228546..67228549,+#_eae95161532de1661d492f51cb15464fp@chr16:67228546..67228549, +
3.29e-195FFCP PHASE2:Hg19::chr2:62801311..62801318,+#_eae95161532de1661d492f51cb15464fp@chr2:62801311..62801318, +
3.29e-195FFCP PHASE1:Hg19::chr11:66676050..66676060,+#_eae95161532de1661d492f51cb15464fp@chr11:66676050..66676060, +
3.29e-195FFCP PHASE1:Hg19::chr11:5255612..5255613,-#_eae95161532de1661d492f51cb15464fp10@HBD
3.29e-195FFCP PHASE1:Hg19::chr17:42343955..42343974,-#_eae95161532de1661d492f51cb15464fp@chr17:42343955..42343974, -
3.29e-195FFCP PHASE2:Hg19::chr21:27203678..27203684,+#_eae95161532de1661d492f51cb15464fp@chr21:27203678..27203684, +
3.29e-195FFCP PHASE1:Hg19::chr1:207823590..207823599,+#_eae95161532de1661d492f51cb15464fp@chr1:207823590..207823599, +
3.29e-195FFCP PHASE2:Hg19::chr20:24432163..24432165,+#_eae95161532de1661d492f51cb15464fp@chr20:24432163..24432165, +
3.29e-195FFCP PHASE1:Hg19::chr11:29581179..29581180,+#_eae95161532de1661d492f51cb15464fp@chr11:29581179..29581180, +
3.29e-195FFCP PHASE2:Hg19::chr1:2250692..2250695,+#_eae95161532de1661d492f51cb15464fp@chr1:2250692..2250695, +
3.29e-195FFCP PHASE1:Hg19::chr1:2250692..2250695,+#_eae95161532de1661d492f51cb15464fp@chr1:2250692..2250695, +
3.29e-195FFCP PHASE2:Hg19::chr18:11740276..11740278,+#_eae95161532de1661d492f51cb15464fp@chr18:11740276..11740278, +
3.29e-195FFCP PHASE2:Hg19::chr13:23969126..23969130,+#_eae95161532de1661d492f51cb15464fp@chr13:23969126..23969130, +
3.29e-195FFCP PHASE2:Hg19::chr1:25598971..25598977,+#_eae95161532de1661d492f51cb15464fp4@RHD
3.29e-195FFCP PHASE1:Hg19::chr1:25598971..25598977,+#_eae95161532de1661d492f51cb15464fp4@RHD
3.29e-195FFCP PHASE1:Hg19::chr17:42392517..42392522,+#_eae95161532de1661d492f51cb15464fp17@RUNDC3A
3.29e-195FFCP PHASE1:Hg19::chr11:5248435..5248444,+#_eae95161532de1661d492f51cb15464fp@chr11:5248435..5248444, +
3.29e-195FFCP PHASE1:Hg19::chr2:62801311..62801318,+#_eae95161532de1661d492f51cb15464fp@chr2:62801311..62801318, +
3.29e-195FFCP PHASE1:Hg19::chr21:27203678..27203684,+#_eae95161532de1661d492f51cb15464fp@chr21:27203678..27203684, +
3.29e-195FFCP PHASE2:Hg19::chr2:87816262..87816269,+#_eae95161532de1661d492f51cb15464fp@chr2:87816262..87816269, +
3.29e-195FFCP PHASE1:Hg19::chr2:87816262..87816269,+#_eae95161532de1661d492f51cb15464fp@chr2:87816262..87816269, +
3.29e-195FFCP PHASE2:Hg19::chr22:30680245..30680254,-#_eae95161532de1661d492f51cb15464fp@chr22:30680245..30680254, -
3.29e-195FFCP PHASE1:Hg19::chr11:5247730..5247736,-#_eae95161532de1661d492f51cb15464fp@chr11:5247730..5247736, -
3.29e-195FFCP PHASE2:Hg19::chr10:94679592..94679594,-#_eae95161532de1661d492f51cb15464fp@chr10:94679592..94679594, -
3.29e-195FFCP PHASE1:Hg19::chr22:30680245..30680254,-#_eae95161532de1661d492f51cb15464fp@chr22:30680245..30680254, -
3.29e-195FFCP PHASE2:Hg19::chr19:1207927..1207939,-#_eae95161532de1661d492f51cb15464fp@chr19:1207927..1207939, -
3.29e-195FFCP PHASE2:Hg19::chr8:138915590..138915591,+#_eae95161532de1661d492f51cb15464fp@chr8:138915590..138915591, +
3.29e-195FFCP PHASE1:Hg19::chr16:67228546..67228549,+#_eae95161532de1661d492f51cb15464fp@chr16:67228546..67228549, +
3.29e-195FFCP PHASE2:Hg19::chr1:220146675..220146678,-#_eae95161532de1661d492f51cb15464fp@chr1:220146675..220146678, -
3.29e-195FFCP PHASE1:Hg19::chr8:138915590..138915591,+#_eae95161532de1661d492f51cb15464fp@chr8:138915590..138915591, +
3.29e-195FFCP PHASE2:Hg19::chr7:23205190..23205198,+#_eae95161532de1661d492f51cb15464fp10@KLHL7
3.29e-195FFCP PHASE2:Hg19::chr13:106256314..106256318,+#_eae95161532de1661d492f51cb15464fp@chr13:106256314..106256318, +
3.29e-195FFCP PHASE2:Hg19::chr17:27188395..27188398,-#_eae95161532de1661d492f51cb15464fp1@MIR451A
3.29e-195FFCP PHASE1:Hg19::chr20:24432163..24432165,+#_eae95161532de1661d492f51cb15464fp@chr20:24432163..24432165, +
3.29e-195FFCP PHASE2:Hg19::chr6:155472342..155472346,-#_eae95161532de1661d492f51cb15464fp@chr6:155472342..155472346, -
3.29e-195FFCP PHASE1:Hg19::chr11:57415965..57415973,+#_eae95161532de1661d492f51cb15464fp5@CLP1
3.29e-195FFCP PHASE2:Hg19::chr11:57416011..57416016,+#_eae95161532de1661d492f51cb15464fp9@CLP1
3.29e-195FFCP PHASE2:Hg19::chr8:63838198..63838201,+#_eae95161532de1661d492f51cb15464fp@chr8:63838198..63838201, +
3.29e-195FFCP PHASE1:Hg19::chr8:63838198..63838201,+#_eae95161532de1661d492f51cb15464fp@chr8:63838198..63838201, +
3.29e-195FFCP PHASE1:Hg19::chr13:78682773..78682778,+#_eae95161532de1661d492f51cb15464fp@chr13:78682773..78682778, +
3.29e-195FFCP PHASE2:Hg19::chr16:15616042..15616045,+#_eae95161532de1661d492f51cb15464fp@chr16:15616042..15616045, +
3.29e-195FFCP PHASE2:Hg19::chr1:95582484..95582492,+#_eae95161532de1661d492f51cb15464fp10@TMEM56
3.29e-195FFCP PHASE1:Hg19::chr1:95582484..95582492,+#_eae95161532de1661d492f51cb15464fp10@TMEM56
3.29e-195FFCP PHASE2:Hg19::chr6:10585661..10585670,+#_eae95161532de1661d492f51cb15464fp26@GCNT2
3.29e-195FFCP PHASE2:Hg19::chr1:25598993..25599007,+#_eae95161532de1661d492f51cb15464fp1@RHD
3.29e-195FFCP PHASE1:Hg19::chr1:25598993..25599007,+#_eae95161532de1661d492f51cb15464fp1@RHD
3.29e-195FFCP PHASE1:Hg19::chr1:220146675..220146678,-#_eae95161532de1661d492f51cb15464fp@chr1:220146675..220146678, -
3.29e-195FFCP PHASE1:Hg19::chr16:227522..227524,+#_eae95161532de1661d492f51cb15464fp@chr16:227522..227524, +

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=CL:0000765&oldid=3275337"